Search results
Author(s):
Mohammad Sahebjalal
,
Nick Curzen
Added:
3 years ago
Antiplatelet therapy (APT) represents a major cornerstone in the secondary prevention of coronary artery disease, along with modifying patients’ risk factors. Furthermore, it has been clear, since early unsuccessful regimens, including warfarin and dypiridamole with aspirin, that it is APT that stops coronary stents from clotting off and causing stent thrombosis.1,2 Specifically, the requirement…
View more
Embolic Protection
Author(s):
Jennifer Franke
,
Horst Sievert
Added:
3 years ago
Article
Author(s):
Kully Sandhu
,
Rob Butler
,
James Nolan
Added:
3 years ago
Percutaneous revascularisation has become the cornerstone of ischaemic heart disease management.1,2 Historically, coronary angiography and intervention was predominantly performed via the common femoral artery.3 However, this procedure has an associated 1.5–9.0 % risk of complications, most of which are related to bleeding at the femoral access site.4 Despite a significant reduction in the…
View more
Author(s):
Upul Wickramarachchi
,
Simon Eccleshall
Added:
3 years ago
Percutaneous coronary interventional techniques and devices have evolved enormously since Gruntzig performed his first coronary angioplasty in 1977. 1 It is now the norm to treat patients with both acute coronary syndrome and stable coronary artery disease with drug-eluting stents. We intend to review the evidence and discuss potential benefits of drug-coated balloon-only angioplasty. These…
View more
Author(s):
Jean-Pierre Bassand
Added:
3 years ago
Anticoagulants and antiplatelet therapies, and revascularisation/ reperfusion with percutaneous coronary interventions (PCIs) or surgery are the mainstay of modern treatment of acute coronary syndromes (ACS) with and without ST-segment elevation. In addition, depending on the clinical presentation, thrombolytic therapy may be necessary in patients with ST-elevation myocardial infarction (MI) who…
View more
Coronary Microvascular Dysfunction
Video Series
Author(s):
Haroon Faraz
Added:
1 year ago
Author(s):
L Christian Napp
Added:
4 years ago
Author(s):
Darren Mylotte
,
Ruben LJ Osnabrugge
,
Giuseppe Martucci
,
et al
Added:
3 years ago
Transcatheter aortic valve implantation (TAVI) has emerged as a safe and efficacious treatment in patients with symptomatic severe aortic stenosis (AS) at high- or excessive-risk for surgical aortic valve replacement.1,2 More recently, TAVI technology has been extended to treating high-risk patients with failing aortic or mitral surgical bioprosthetic valves, bicuspid aortic stenosis, pure aortic…
View more
Author(s):
Jubin Joseph
,
Tiffany Patterson
,
Satpal Arri
,
et al
Added:
3 years ago
Cardiogenic shock is a clinical condition of inadequate end-organ perfusion due to cardiac dysfunction (see Table 1). It most commonly occurs in the setting of acute MI with left ventricular failure (~80 % cases),1,2 but can also be caused by right ventricular infarction or late mechanical complications, such as acute mitral regurgitation or ventricular rupture (septal or free wall). Non-infarct…
View more